WP
WST icon

WealthShield Partners’s West Pharmaceutical WST Stock Holding History

WealthShield Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-511
Closed -$184K – 753
2021
Q2 		$184K Buy
511
+291
+132% +$96.1K 0.03% 272
2021
Q1 		$62K Buy
+220
New +$63K 0.01% 410

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

WealthShield Partners's WST Position: Q3 2021 in Review

WealthShield Partners sold out of West Pharmaceutical (WST) in Q3 2021, closing a stake of 511 shares — an estimated $184K sold.

WealthShield Partners first reported a position in WST in Q1 2021 and held it in 2 quarters. The position peaked at $184K in Q2 2021. 670 funds tracked by Wall St. Rank hold WST as of Q3 2021.

  • WealthShield Partners reported no remaining West Pharmaceutical position as of Q3 2021 after selling out during the quarter.
  • WealthShield Partners sold 511 West Pharmaceutical shares in Q3 2021, an estimated $184K.
  • WealthShield Partners first reported a position in West Pharmaceutical in Q1 2021 and held it in 2 quarters.
  • WealthShield Partners's West Pharmaceutical position peaked at $184K in Q2 2021.
  • 670 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2021.

Based on WealthShield Partners's 13F filing for Q3 2021, filed 12 Nov 2021.